A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer

Condition:   Cervical Cancer Interventions:   Drug: TQB2868 injection;   Drug: Paclitaxel injection;   Drug: Cisplatin injection;   Drug: Carboplatin injection;   Drug: Bevacizumab injection Sponsor:   Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials